Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Reply to Correspondence

Reply to correspondence on “Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C”

Chen-Hua Liu, Yu-Ping Chang

Clin Mol Hepatol. 2025;31(2):e232-e233. Published online February 26, 2025

DOI: https://doi.org/10.3350/cmh.2025.0203

View: 257 Download: 16

Editorial

Toward hepatitis C virus elimination using artificial intelligence

Moon Haeng Hur, Jeong-Hoon Lee

Clin Mol Hepatol. 2024;30(2):147-149. Published online February 23, 2024

DOI: https://doi.org/10.3350/cmh.2024.0135

View: 3082 Download: 93 Crossref: 2

Original Article

An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection

Youn Jae Lee, Jeong Heo, Do Young Kim, Woo Jin Chung, Won Young Tak, Yoon Jun Kim, Seung Woon Paik, Eungeol Sim, Susila Kulasingam, Rohit Talwani, Barbara Haber, Peggy Hwang

Clin Mol Hepatol. 2019;25(4):400-407. Published online May 28, 2019

DOI: https://doi.org/10.3350/cmh.2019.0006

View: 7156 Download: 132 Web of Science: 9 Crossref: 7

Review

Development and surveillance of hepatocellular carcinoma in patients with sustained virologic response after antiviral therapy for chronic hepatitis C

Seong Kyun Na, Byung-Cheol Song

Clin Mol Hepatol. 2019;25(3):234-244. Published online January 21, 2019

DOI: https://doi.org/10.3350/cmh.2018.0108

View: 9369 Download: 253 Web of Science: 24 Crossref: 26

Original Article

A reduced dose of ribavirin does not influence the virologic response during pegylated interferon alpha-2b and ribavirin combination therapy in patients with genotype 1 chronic hepatitis C

Byung Chul You, Young Seok Kim, Hun il Kim, Se Hun Kim, Seung Sik Park, Yu Ri Seo, Sang Gyune Kim, Se Whan Lee, Hong Soo Kim, Soung Won Jeong, Jae Young Jang, Boo Sung Kim

Clin Mol Hepatol. 2012;18(3):272-278. Published online September 25, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.3.272

View: 8233 Download: 43 Crossref: 1

The Korean Journal of Hepatology Elsewhere

Role of vitamin D in chronic hepatitis C

Tae Yeob Kim

Clin Mol Hepatol. 2011;17(2):170-172. Published online June 23, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.2.170

View: 6265 Download: 41

Durability of a sustained virologic response in patients with chronic hepatitis C treated with peginterferon and ribavirin

Kyung-Ah Kim

Clin Mol Hepatol. 2011;17(1):84-86. Published online March 21, 2011

DOI: https://doi.org/10.3350/kjhep.2011.17.1.84

View: 6138 Download: 39 Crossref: 1

3

Mutations within the interferon sensitivity determining region in Korean patients infected with hepatitis C virus genotype 1b

Young-Joo Jin, M.D., Yoon Kyung Park, M.D., Gui Jun Yun, M.D. Han Chu Lee, M.D., Sook-Hyang Jeong, M.D. Gang Mo Kim, M.D., Young-Suk Lim, M.D., Young-Hwa Chung, M.D., Yung Sang Lee, M.D., Dong Jin Suh, M.D.

Clin Mol Hepatol. 2010;16(2):158-167. Published online June 25, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.2.158

View: 4833 Download: 27

Effects of pegylated interferon and ribavirin in Korean patients with chronic hepatitis C virus infection

Myoung Joo Kang, M.D., Eun Uk Jung, M.D., Sang Won Park, M.D., Paul Choi, M.D., Ji Hyun Kim, M.D., Sung Jae Park, M.D., Eun Taek Park, M.D., Youn Jae Lee, M.D., Sang Hyuk Lee, M.D., Sang Yong Seol, M.D.

Clin Mol Hepatol. 2008;14(3):318-330. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.318

View: 5875 Download: 38 Crossref: 18

Original Article

Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized Trial

Hyung Joon Yim, Yeon Seok Seo, Ji Hoon Kim, Won Kim, Young Kul Jung, Jae Young Jang, Sae Hwan Lee, Yun Soo Kim, Chang Wook Kim, Hyoung Su Kim, Jae-Jun Shim, Eun-Young Cho, In Hee Kim, Byung Seok Lee, Jeong-Hoon Lee, Byung Seok Kim, Jeong Won Jang, Hyun Woong Lee, Jung Hyun Kwon, Moon Young Kim, Do Seon Song, Jung Gil Park, Yoon Seok Lee, Eileen L. Yoon, Han Ah Lee, Seong Hee Kang, Jin Mo Yang

Received September 19, 2024 Accepted January 16, 2025

DOI: https://doi.org/10.3350/cmh.2024.0819 [Accepted]

View: 1384 Download: 70

1 |

Viewed By 8335	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7316	MAFLD: How is it different from NAFLD?
Viewed By 5293	Global incidence and prevalence of nonalcoholic fatty liver disease
Viewed By 4950	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4523	Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease

Cited By 319	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 291	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 186	MAFLD: How is it different from NAFLD?
Cited By 101	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 92	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search